P, B., AR, M., A, K., B, T., ML, B., C, L., & D, E. (2024). Integrating a Polygenic Risk Score into a clinical setting would impact risk predictions in familial breast cancer. Journal of medical genetics, 61(2), 150. https://doi.org/10.1136/jmg-2023-109311
Chicago Style (17th ed.) CitationP, Baliakas, Munters AR, Kämpe A, Tesi B, Bondeson ML, Ladenvall C, and Eriksson D. "Integrating a Polygenic Risk Score into a Clinical Setting Would Impact Risk Predictions in Familial Breast Cancer." Journal of Medical Genetics 61, no. 2 (2024): 150. https://doi.org/10.1136/jmg-2023-109311.
MLA (9th ed.) CitationP, Baliakas, et al. "Integrating a Polygenic Risk Score into a Clinical Setting Would Impact Risk Predictions in Familial Breast Cancer." Journal of Medical Genetics, vol. 61, no. 2, 2024, p. 150, https://doi.org/10.1136/jmg-2023-109311.